Concepedia

Penny Towne

PT

Statistics

Publications

5

Citations

1.4K

H-Index

5

Active since

2013

Affiliations

Ventana Research Corporation (United States)(Current)

Roche (United States)

Human Genome Sciences (United States)

Pfizer (United States)

Penny Towne is an author at Ventana Research Corporation (United States) specializing in medicine, molecular oncology, and oncology.

Publications per year

2013–2022

5

Publications

5

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +14

A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib

Trish Thorne-Nuzzo, Crystal Williams, Alice Catallini et al. · Journal of Thoracic Oncology · 2017 · 57 citations · Full text

Medicine, Oncology, Pharmacology +16

New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay

Hiroaki Nitta, Koji Tsuta, Akihiko Yoshida et al. · Journal of Thoracic Oncology · 2013 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +13

Activity of trastuzumab emtansine (T-DM1) in 3D cell culture

Jean Z. Boyer, Gail D. Lewis Phillips, Hiro Nitta et al. · Breast Cancer Research and Treatment · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

High-Resolution Epitope Mapping and Affinity Binding Analysis Comparing a New Anti-Human LAG3 Rabbit Antibody Clone to the Commonly Used Mouse 17B4 Clone

P. Daniel Warren, Mark S. Dodson, Margaret H. Smith et al. · Antibodies · 2022 · 12 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 5